BioWest Therapeutics Inc Report issue

For profit Phase 2 Phase 3
Founded: Vancouver BC Canada (2010)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

omiganan (3 trials)

Drugs in Phase 2 Trials (3)

interferon alpha-2b (Intron-A) (1 trial)

mdl 28574 (4 trials)

ribavirin (virazole) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Bacteremia (Phase 3)

Fungemia (Phase 3)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 4